@article{1da1c3c3050348c49a5b2955776511d0,
title = "Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial",
keywords = "herpes zoster vaccine, immunogenicity, immunosuppressive chemotherapy, patients with solid tumors, safety",
author = "{on behalf of the Zoster-028 Study Group} and Peter Vink and {Delgado Mingorance}, Ignacio and {Maximiano Alonso}, Constanza and Belen Rubio-Viqueira and Jung, {Kyung Hae} and {Rodriguez Moreno}, {Juan Francisco} and Enrique Grande and {Marrupe Gonzalez}, David and Sarah Lowndes and Javier Puente and Hartmut Kristeleit and David Farrugia and McNeil, {Shelly A.} and Laura Campora and {Di Paolo}, Emmanuel and {El Idrissi}, Mohamed and Olivier Godeaux and Marta L{\'o}pez-Fauqued and Bruno Salaun and Heineman, {Thomas C.} and Lidia Oostvogels",
note = "Publisher Copyright: {\textcopyright} 2019 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society",
year = "2019",
month = apr,
day = "15",
doi = "10.1002/cncr.31909",
language = "English",
volume = "125",
pages = "1301--1312",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",
}
